Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma

Published:2011-05 Issue:5 Volume:46 Page:341-349
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:Investigative Radiology

Author:

Lin Chieh,Itti Emmanuel,Luciani Alain,Zegai Benhalima,Lin Shih-jui,Kuhnowski Frédérique,Pigneur Frédéric,Gaillard Isabelle,Paone Gaetano,Meignan Michel,Haioun Corinne,Rahmouni Alain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Extracranial applications of diffusion-weighted magnetic resonance imaging

2. Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

3. Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

4. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

5. Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of diffusion-weighted MRI and [18F]FDG PET/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma;European Radiology;2023-08-05

2. Diffusion Weighted Imaging in Spine Tumors;Neuroimaging Clinics of North America;2023-08

3. Diffusion and Perfusion Imaging in Post-Treatment Evaluation of the Head and Neck;Seminars in Roentgenology;2023-07

4. IRM corps entier et lymphomes;IRM Corps Entier;2023

5. Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy;Cancer Imaging;2022-12-27